US FDA Getting More Money Up Front Under Cures Bill Revisions
Additional funding would arrive beginning in FY 2017 as House pushes bill to Senate.
You may also be interested in...
Budget authority increase for medical product safety is coupled with additional funds for coronavirus countermeasure development and advanced manufacturing.
After two years of significant growth in non-user fee funds, House appropriators offer FDA a more modest increase for FY 2021.
President Trump's budget request would boost compounding and vaccines by $5m, but human drugs program would lose $4.8m in training funds.